BioSig Technologies, Inc. announces its intention to offer shares of common stock (or pre-funded warrants) through a public offering.
The offering is underwritten, and the net proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers for the offering.
Public Offering Announcement
BioSig Technologies intends to offer shares of common stock through an underwritten public offering, with the net proceeds allocated for specific purposes.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
SEC Registration
The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
- The company's decision to offer shares through a public offering indicates a strategic move to raise capital for investment purposes.
- The involvement of Clear Street and Needham & Company as joint book-running managers adds credibility to the offering and may attract investor interest.
BioSig Technologies' announcement of the public offering reflects its strategic financial planning and intention to utilize the proceeds for investment and operational needs.